<DOC>
	<DOCNO>NCT01300975</DOCNO>
	<brief_summary>Intralesional injection antimony use L major Iran modest cure rate [ 56 % : Asilian 2004 ] . However , therapeutic approach use L braziliensis Brazil , attractive cure rate 3 month 80 % [ Oliveira-Neto 1997 ] . Because intralesional Sb injection local therapy best report cure rate South American L braziliensis disease , species cause disease Bolivia , pilot study local therapy bolivian L braziliensis disease evaluate intralesional Sb therapy .</brief_summary>
	<brief_title>Intralesional Antimony Bolivian Cutaneous Leishmaniasis</brief_title>
	<detailed_description>Cutaneous leishmaniasis endemic New World approximately US-Mexican border Central America Northern part South America level Rio de Janeiro . Until recently , standard treatment leishmaniases pentavalent antimony ( Glucantime Pentostam ) . The cure rate L panamensis Colombia 91 % -93 % [ Soto , 1993 ; Velez , 1997 ] , large study several formulation antimony find combined Bolivia-Colombia cure rate 86 % [ Soto , 2004b ] , cure rate Palos Blancos , Bolivia 15 16 = 94 % [ Soto , 2008 ] . Nevertheless , pentavalent antimonials disadvantage multiple injection least 3 week mild-moderate clinical toxicity : local pain site injection generalize myalgias arthralgia severe responsible partial definitive interruption therapy , gastrointestinal complaint , liver enzyme elevation , pancreatic enzyme elevation rarely danger life ventricular repolarization problem [ Soto , 2005 , Velez 2010 ] , particularly unpleasant localize moderate clinical problem cutaneous leishmaniasis usually dangerous patient . The oral agent Miltefosine show effective antimony Colombia Bolivia . In Colombia , cure rate miltefosine 91 % [ Soto 2004a ] just-completed trial Palos Blancos , cure rate miltefosine 32 37 = 88 % . Side effect see patient cutaneous disease specifically attribute drug nausea vomit mild grade approximately 25 % patient , low-grade elevation creatinine also approximately 25 % patient [ Soto 2001 ; Soto 2004 ] . Now cutaneous leishmaniasis affect woman reproductive age , crucial inconvenient miltefosine ca n't take pregnancy breastfeed ; additionally prolong course ( 4 week ) make difficult adherence therapy emerge risk incomplete treatment might necessary supervise administration full course . For small , single lesion , side effect cost systemic therapy antimony miltefosine may outweigh advantage cure . For lesion , target local therapy would attractive effective . The cost good low , systemic adverse event would non-existent . For reason , topical treatment leishmaniases presently subject intense worldwide interest , include recent [ July 2010 ] PAHO meeting Colombia . The lead candidate topical formulation paromomyin , local heat since cutaneous leishmania heat-sensitive , local freeze per dermatologic lesion , intralesional injection antimony . The ability topical formulation paromomycin cure depend penetration divalent cation lesion thus depend precise formula cream paromomycin dissolve . Other combination paromomycin plus MBCL Vaseline , minimal efficacy Colombia [ Soto 1998 ] , patent paromomycin-containing cream investigation obtain except Pharma . Reports local thermotherapy publish , key issue penetration agent [ case , heat ] lesion best approach difficult utilize require $ 25,000 machine exists risk infection via electrode . Intralesional injection antimony also use L major Iran , also modest cure rate [ 56 % : Asilian 2004 ] . However , therapeutic approach use L braziliensis Brazil , attractive cure rate 3 month 80 % [ Oliveira-Neto 1997 ] . Because intralesional Sb injection local therapy best report cure rate South American L braziliensis disease , species cause disease Bolivia , pilot study local therapy bolivian L braziliensis disease evaluate intralesional Sb therapy . Cryotherapy use sole therapy L major Iran . The cure rate modest : 50-60 % [ Asilian 2004 ; Layegh 2009 ] . Nevertheless , cryotherapy may attractive cure rate L braziliensis . Therefore , cryotherapy also evaluate pilot study . Patients receive intralesional Sb randomize vs v patient receive cryotherapy also vs patient receive emollient cream Because Il Sb perhaps promise cryotherapy , patient receive Il Sb ( 30 ) receive cryotherapy ( 20 ) The emollient cream may improve host response trauma parasitic process , nevertheless , emollient cream placebo treatment specifically antiparasitic sense . The spontaneous rate cure unknown Bolivia , thus group serve establish key value permit comparison IL Sb rate cryotherapy rate . Although 20 patient randomize `` placebo '' group , stop rule 4 early patient 6 total patient group fail , `` placebo '' patient enter trial .</detailed_description>
	<mesh_term>Leishmaniasis</mesh_term>
	<mesh_term>Leishmaniasis , Cutaneous</mesh_term>
	<criteria>INCLUSION CRITERIA : Gender : Male female Age : &gt; 12 yr age Clinicla presentation : 12 ulcerative lesion , &lt; 30 mm large diameter , total lesion area &lt; 900 mm2 . Parasitological confirmation lesion make visualization culture leishmania biopsy aspirate lesion . EXCLUSION CRITERIA : Previous treatment leishmaniasis : therapy Sb , pentamidine , amphotericin B , miltefosine , imidazoles allopurinol last 3 month Concomitant disease history would likely PI 's opinion interact , either positively negatively , IL Sb treatment .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>Leishmaniasis</keyword>
	<keyword>intralesional antimony</keyword>
	<keyword>cryotherapy</keyword>
</DOC>